Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Conavi Medical Corp V.TMD


Primary Symbol: T.TMD

Conavi Medical Corp., formerly Titan Medical Inc., is a Canada-based company. The Company is focused on designing, manufacturing, and marketing imaging technologies to guide common minimally invasive cardiovascular procedures. The Novasight Hybrid System is intended for intravascular imaging of coronary arteries and is indicated in patients who are candidates for transluminal interventional procedures. Its Novasight Hybrid System combines both intravascular ultrasound (IVUS) and optical coherence tomography (OCT) to enable simultaneous and co-registered imaging of coronary arteries. Hybrid IVUS and OCT imaging provides additional information over single modality imaging in complex lesions. The versatility of hybrid imaging is useful for a variety of complex percutaneous coronary intervention (PCIs), including situations where the customer may want to image large ostial lesions with IVUS but also use OCT for diseased distal lesions and/or stent assessment.


TSX:TMD - Post by User

Bullboard Posts
Post by Ducimuson Aug 19, 2010 8:25am
861 Views
Post# 17364300

Ducimus adds TMD.V to his watchlist.

Ducimus adds TMD.V to his watchlist.Having examined the chart of each of the stocks returned on tonight's market scan, this stock attracts
my attention by displaying characteristics signalling a potential entry into Stage II. I therefore added it
to my watchlist.

The market scan uses a "Stockcharts" scan syntax I personally developed, in order to identify stocks
likely to display the characteristics of stocks entering Stage II, as described by Stan Weinstein. The
principal scan criteria are basically set to identify stocks whose price is above their 150-day Moving
Average and whose daily volume is at least 50,000 and exceed by a margin of 3:1 the usual volume
levels displayed in the last 2 months.

Bullboard Posts